Clincosm LogoSign in Get a demo

PRURITCC: Itch and Pain Characteristics in Skin Carcinomas

Sponsor
University Hospital, Brest (Other)
Overall Status
Completed
CT.gov ID
NCT03290989
Collaborator
(none)
100
Enrollment
1
Location
4
Actual Duration (Months)
25.2
Patients Per Site Per Month

Study Details

Study Description

Brief Summary

The objective of this study is to have better knowledge about sensations of patients with skin carcinomas and to have data about characteristics of pain and pruritus . All patients presenting with a suspicions lesion for skin carcinomas will be included and will respond to a questionnaire. Demographics data, and histological data about skin carcinomas will be collected.

Condition or Disease Intervention/Treatment Phase

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    100 participants
    Observational Model:
    Case-Only
    Time Perspective:
    Prospective
    Official Title:
    Itch and Pain Characteristics in Skin Carcinomas
    Actual Study Start Date :
    Apr 1, 2015
    Actual Primary Completion Date :
    Apr 1, 2015
    Actual Study Completion Date :
    Jul 31, 2015

    Outcome Measures

    Primary Outcome Measures

    1. Evaluate characteristics of pruritus in skin carcinomas [Day1 (when presenting at consultation with a skin lesion suspicious for carcinoma)]

      Questions about characteristics

    2. Evaluate characteristics of pruritus in skin carcinomas [Day1 (when presenting at consultation with a skin lesion suspicious for carcinoma]

      Numerical visual scale (EVA)

    3. Evaluate characteristics of pruritus in skin carcinomas [Day1 (when presenting at consultation with a skin lesion suspicious for carcinoma]

      5D-itch scale

    4. Evaluate characteristics of pain in skin carcinomas [Day1 (when presenting at consultation with a skin lesion suspicious for carcinoma]

      Numerical visual pain

    5. Evaluate characteristics of in skin carcinomas [Day1 (when presenting at consultation with a skin lesion suspicious for carcinoma]

      score DN4

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:

    all patients with suspected skin carcinoma aged 18 years or more

    Exclusion Criteria:

    • age under 18 years,

    • inability to complete the questionnaire because of cognitive impairment

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 CHRU de Brest Brest France 29609

    Sponsors and Collaborators

    • University Hospital, Brest

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    University Hospital, Brest
    ClinicalTrials.gov Identifier:
    NCT03290989
    Other Study ID Numbers:
    • PRURITCC
    First Posted:
    Sep 25, 2017
    Last Update Posted:
    Sep 25, 2017
    Last Verified:
    Sep 1, 2017
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Additional relevant MeSH terms:
    Carcinoma
    Skin Neoplasms
    Pruritus

    Study Results

    No Results Posted as of Sep 25, 2017